Drug Profile
Research programme: nitric oxide synthase type II inhibitors - Adolor Corporation
Alternative Names: BBS-2; iNOS dimerisation inhibitors - Adolor Corporation; iNOS inhibitors - Adolor CorporationLatest Information Update: 11 Mar 2009
Price :
$50
*
At a glance
- Originator Adolor Corporation
- Class
- Mechanism of Action Immunosuppressants; Nitric oxide synthase type II inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Inflammation; Neuropathic pain
- Discontinued Autoimmune disorders
Most Recent Events
- 07 Sep 2007 Preclinical trials in Autoimmune disorders in USA (unspecified route)
- 07 Sep 2007 Preclinical trials in Inflammation in USA (unspecified route)
- 07 Sep 2007 Preclinical trials in Neuropathic pain in USA (unspecified route)